Satoshi Yanagisawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Satoshi Yanagisawa has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Toyoaki Murohara
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
102 shared publicationsYasuya Inden
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
66 shared publications- Yasuya Inden
Department of Cardiology Nagoya University Graduate School of Medicine Nagoya Japan
44 shared publications Rei Shibata
Department of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine
34 shared publicationsHiroyuki Kato
Division of Cardiology, Japan Community Healthcare Organization Chukyo Hospital
29 shared publicationsMasafumi Shimojo
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
29 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5)
Ablation at the Coronary Sinus Diverticular Neck for a Posteroseptal Accessory Pathway With Coronary Sinus Ostial Atresia
- 21 September 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (5)
Open AccessAblation at the Coronary Sinus Diverticular Neck for a Posteroseptal Accessory Pathway With Coronary Sinus Ostial Atresia
- 26 July 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Contact Index for PulseSelect Catheter Apposition: Validation by Transesophageal Echocardiography
Background: Reliable catheter–tissue apposition is important for effective pulmonary vein isolation using pulsed field ablation. The contact index, derived from real‐time impedance rise on the EnSite X mapping system, may provide an objective surrogate for catheter contact; however, its utility with the PulseSelect catheter remains insufficiently defined. Methods: In this single‐center pilot study, patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation with the PulseSelect catheter under general anesthesia were evaluated. High‐resolution transesophageal echocardiography was used as the reference standard to classify electrode‐level catheter apposition as contact or non‐contact. Contact index values from electrodes 3–7 were paired with transesophageal echocardiography findings, and receiver operating characteristic curve analysis was performed. Results: A total of 316 paired imaging–electrical data points were analyzed. Interobserver agreement for transesophageal echocardiography‐based contact assessment was excellent (Cohen's κ = 0.86). Contact index values were higher at contact than non‐contact segments. A contact index cutoff of 10% yielded an area under the curve of 0.864, with 76.1% sensitivity and 82.9% specificity. In the central electrodes 4–6, the area under the curve was 0.871, with 80.1% sensitivity and 81.2% specificity. Conclusions: Contact index was associated with transesophageal echocardiography‐confirmed catheter–tissue apposition during pulsed field ablation using the PulseSelect catheter. A 10% threshold may be a useful candidate reference for real‐time apposition assessment, requiring validation in larger studies.
- 26 July 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Contact Index for PulseSelect Catheter Apposition: Validation by Transesophageal Echocardiography
Background: Reliable catheter–tissue apposition is important for effective pulmonary vein isolation using pulsed field ablation. The contact index, derived from real‐time impedance rise on the EnSite X mapping system, may provide an objective surrogate for catheter contact; however, its utility with the PulseSelect catheter remains insufficiently defined. Methods: In this single‐center pilot study, patients with paroxysmal atrial fibrillation undergoing pulmonary vein isolation with the PulseSelect catheter under general anesthesia were evaluated. High‐resolution transesophageal echocardiography was used as the reference standard to classify electrode‐level catheter apposition as contact or non‐contact. Contact index values from electrodes 3–7 were paired with transesophageal echocardiography findings, and receiver operating characteristic curve analysis was performed. Results: A total of 316 paired imaging–electrical data points were analyzed. Interobserver agreement for transesophageal echocardiography‐based contact assessment was excellent (Cohen's κ = 0.86). Contact index values were higher at contact than non‐contact segments. A contact index cutoff of 10% yielded an area under the curve of 0.864, with 76.1% sensitivity and 82.9% specificity. In the central electrodes 4–6, the area under the curve was 0.871, with 80.1% sensitivity and 81.2% specificity. Conclusions: Contact index was associated with transesophageal echocardiography‐confirmed catheter–tissue apposition during pulsed field ablation using the PulseSelect catheter. A 10% threshold may be a useful candidate reference for real‐time apposition assessment, requiring validation in larger studies.
- Open Access
- 9 July 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (9) , 1063-1067
Timely transmission of alert events and prompt management of ventricular arrhythmias using app-based remote monitoring in a patient with cardiac implantable electronic devices
- 9 July 2026
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (9) , 1063-1067
Open AccessTimely transmission of alert events and prompt management of ventricular arrhythmias using app-based remote monitoring in a patient with cardiac implantable electronic devices
- Open Access
- 7 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1286-1289
Smartphone-Based Remote Monitoring for Cardiac Implantable Electronic Devices
- 7 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1286-1289
Open AccessSmartphone-Based Remote Monitoring for Cardiac Implantable Electronic Devices
- Open Access
- 2 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (7) , ytag514
Novel technique for leadless pacemaker implantation in the small right atrial appendage: a case report
Background: An atrial leadless pacemaker (Aveir AR [Abbott]) has recently become available, enabling atrial pacing and maintaining strict atrioventricular synchronization. Although the efficacy and safety of leadless pacemakers have already been reported, some cases present challenges during implantation due to anatomical variations. Case summary: A 66-year-old man visited our hospital complaining of dizziness. A 12-lead electrocardiogram exhibited junctional rhythm with a heart rate of 40 beats/min. A leadless pacemaker was implanted instead of a transvenous pacemaker because of daily oral steroid administration and the risk of a pocket infection. The Aveir AR delivery catheter was guided to the base of the right atrial appendage (RAA) using deflection manoeuvres. However, upon deflection release, the catheter tip slipped towards the superior vena cava because of the significantly small RAA. To avoid catheter tip slip, the catheter lever was turned clockwise to rotate the chevron marker one-quarter from its initial position while maintaining deflection. Mapping measurements obtained while maintaining catheter deflection were favourable. Even after releasing the deflection, the catheter tip position remained stable at the RAA base without slippage. Subsequently, the delivery catheter deflection was released, and the chevron marker 1 1/2 was rotated under fluoroscopy. The Aveir AR position and each final parameter were favourable. No adverse events, including cardiac tamponade and dislodgement, were recorded. Discussion: This case highlights the specific bailout technique using partial rotation while maintaining deflection for Aveir AR implantation in a markedly small RAA; however, it should not replace standard implantation technique.
- 2 July 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (7) , ytag514
Open AccessNovel technique for leadless pacemaker implantation in the small right atrial appendage: a case report
Background: An atrial leadless pacemaker (Aveir AR [Abbott]) has recently become available, enabling atrial pacing and maintaining strict atrioventricular synchronization. Although the efficacy and safety of leadless pacemakers have already been reported, some cases present challenges during implantation due to anatomical variations. Case summary: A 66-year-old man visited our hospital complaining of dizziness. A 12-lead electrocardiogram exhibited junctional rhythm with a heart rate of 40 beats/min. A leadless pacemaker was implanted instead of a transvenous pacemaker because of daily oral steroid administration and the risk of a pocket infection. The Aveir AR delivery catheter was guided to the base of the right atrial appendage (RAA) using deflection manoeuvres. However, upon deflection release, the catheter tip slipped towards the superior vena cava because of the significantly small RAA. To avoid catheter tip slip, the catheter lever was turned clockwise to rotate the chevron marker one-quarter from its initial position while maintaining deflection. Mapping measurements obtained while maintaining catheter deflection were favourable. Even after releasing the deflection, the catheter tip position remained stable at the RAA base without slippage. Subsequently, the delivery catheter deflection was released, and the chevron marker 1 1/2 was rotated under fluoroscopy. The Aveir AR position and each final parameter were favourable. No adverse events, including cardiac tamponade and dislodgement, were recorded. Discussion: This case highlights the specific bailout technique using partial rotation while maintaining deflection for Aveir AR implantation in a markedly small RAA; however, it should not replace standard implantation technique.
- 25 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade
Introduction: Procedure‐related cardiac tamponade remains a serious complication of invasive arrhythmia procedures. Although andexanet alfa has been used for refractory pericardial bleeding in patients receiving factor Xa inhibitors, little is known about temporal changes in coagulation biomarkers after its administration in this setting. Methods and Results: We conducted a single‐center retrospective observational study of 15 patients with cardiac tamponade secondary to procedure‐related cardiac injury between January 2019 and December 2025. Patients were classified according to andexanet alfa use during tamponade management. Coagulation parameters were evaluated at predefined time points from before tamponade onset through day three. Analyses were primarily descriptive. Of the 15 patients, four were treated with andexanet alfa and 11 were managed without andexanet alfa. All patients in the andexanet alfa group were receiving edoxaban for atrial fibrillation. Hemostasis was achieved in all patients after andexanet alfa administration. Patients treated with andexanet alfa showed a distinctive temporal biomarker pattern, characterized by a more pronounced rise in thrombin‐antithrombin complex and prothrombin fragment 1 + 2 at the early post‐hemostasis time point, whereas D‐dimer showed little apparent change at this time point and appeared to be higher on day one. No thromboembolic complications occurred in the andexanet alfa group during hospitalization. Conclusion: In this small descriptive cohort, andexanet alfa administration was followed by prompt hemostasis in all treated patients, while also being accompanied by early increases in thrombin‐generation markers and later evidence of fibrin turnover. These hypothesis‐generating findings support careful use of andexanet alfa as rescue therapy with attention to potential early procoagulant changes.
- 25 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
Temporal Coagulation Biomarker Profiles After Andexanet Alfa Use for Procedure‐Related Cardiac Tamponade
Introduction: Procedure‐related cardiac tamponade remains a serious complication of invasive arrhythmia procedures. Although andexanet alfa has been used for refractory pericardial bleeding in patients receiving factor Xa inhibitors, little is known about temporal changes in coagulation biomarkers after its administration in this setting. Methods and Results: We conducted a single‐center retrospective observational study of 15 patients with cardiac tamponade secondary to procedure‐related cardiac injury between January 2019 and December 2025. Patients were classified according to andexanet alfa use during tamponade management. Coagulation parameters were evaluated at predefined time points from before tamponade onset through day three. Analyses were primarily descriptive. Of the 15 patients, four were treated with andexanet alfa and 11 were managed without andexanet alfa. All patients in the andexanet alfa group were receiving edoxaban for atrial fibrillation. Hemostasis was achieved in all patients after andexanet alfa administration. Patients treated with andexanet alfa showed a distinctive temporal biomarker pattern, characterized by a more pronounced rise in thrombin‐antithrombin complex and prothrombin fragment 1 + 2 at the early post‐hemostasis time point, whereas D‐dimer showed little apparent change at this time point and appeared to be higher on day one. No thromboembolic complications occurred in the andexanet alfa group during hospitalization. Conclusion: In this small descriptive cohort, andexanet alfa administration was followed by prompt hemostasis in all treated patients, while also being accompanied by early increases in thrombin‐generation markers and later evidence of fibrin turnover. These hypothesis‐generating findings support careful use of andexanet alfa as rescue therapy with attention to potential early procoagulant changes.
- Open Access
- 25 June 2026
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 90 (7) , 871-880
Long-Term Prognosis and Outcomes in Patients Undergoing His Bundle Pacing Implantation ― A Multicenter, Prospective Observational Study in Japan ―
Background: His bundle (HB) pacing (HBP) can achieve an ideal pattern of ventricular activation. The long-term efficacy and clinical outcomes of HBP in Japan remain unclear.Methods and Results: This multicenter prospective observational study enrolled 115 patients undergoing HBP implantation at 8 experienced centers in Japan. Inclusion criteria comprised atrioventricular block or conduction disturbance and an anticipated ventricular pacing of ≥40% in patients scheduled for HBP implantation. All patients were followed for 3 years after implantation. The primary endpoints were all-cause mortality, hospitalization for heart failure, and upgrade to cardiac resynchronization therapy. Secondary endpoints were changes in echocardiographic parameters and laboratory biomarkers after implantation. Seventy-eight (68%) patients continued HBP after the procedure (procedural success), whereas 68 (59%) patients exhibited clinical success (HB capture threshold ≤2.5 V at 1.0 ms). Six months after implantation, echocardiographic parameters improved, and brain B-type natriuretic peptide (BNP) levels decreased substantially. Major adverse clinical events (MACE), defined as the composite of the primary endpoints, occurred in 16 (21%) patients; 18 (23%) patients discontinued HBP during the follow-up period. Multivariable analysis identified elevated BNP levels at baseline as an independent predictor of MACE.Conclusions: HBP implantation presents technical challenges and exhibits a moderate success rate in real-world clinical practice. The high incidence of elevated HB capture thresholds and HBP abandonment mean that careful patient selection and rigorous long-term surveillance are required.
- 25 June 2026
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 90 (7) , 871-880
Open AccessLong-Term Prognosis and Outcomes in Patients Undergoing His Bundle Pacing Implantation ― A Multicenter, Prospective Observational Study in Japan ―
Background: His bundle (HB) pacing (HBP) can achieve an ideal pattern of ventricular activation. The long-term efficacy and clinical outcomes of HBP in Japan remain unclear.Methods and Results: This multicenter prospective observational study enrolled 115 patients undergoing HBP implantation at 8 experienced centers in Japan. Inclusion criteria comprised atrioventricular block or conduction disturbance and an anticipated ventricular pacing of ≥40% in patients scheduled for HBP implantation. All patients were followed for 3 years after implantation. The primary endpoints were all-cause mortality, hospitalization for heart failure, and upgrade to cardiac resynchronization therapy. Secondary endpoints were changes in echocardiographic parameters and laboratory biomarkers after implantation. Seventy-eight (68%) patients continued HBP after the procedure (procedural success), whereas 68 (59%) patients exhibited clinical success (HB capture threshold ≤2.5 V at 1.0 ms). Six months after implantation, echocardiographic parameters improved, and brain B-type natriuretic peptide (BNP) levels decreased substantially. Major adverse clinical events (MACE), defined as the composite of the primary endpoints, occurred in 16 (21%) patients; 18 (23%) patients discontinued HBP during the follow-up period. Multivariable analysis identified elevated BNP levels at baseline as an independent predictor of MACE.Conclusions: HBP implantation presents technical challenges and exhibits a moderate success rate in real-world clinical practice. The high incidence of elevated HB capture thresholds and HBP abandonment mean that careful patient selection and rigorous long-term surveillance are required.
- Open Access
- 15 May 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (24) , 108340
Successful Sealing of Steam Pop–Related Left Ventricular Summit Perforation With Partial Impella Support
- 15 May 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (24) , 108340
Open AccessSuccessful Sealing of Steam Pop–Related Left Ventricular Summit Perforation With Partial Impella Support
- Open Access
- 6 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1282-1285
Differential Time Course of LVEF Recovery Between Conduction System Pacing Versus Biventricular Pacing
- 6 May 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (7) , 1282-1285
Open AccessDifferential Time Course of LVEF Recovery Between Conduction System Pacing Versus Biventricular Pacing